Cancer—the Evolutionary Legacy

Por Leonard, R C F
Publicado em 2001

Advances in Cancer Research, vol 42

Por Leonard, R C F
Publicado em 1986

Progress in Cancer Control IV: Research in the Cancer Center: Progress in Clinical and Biological Research, vol 130

Por Leonard, R C F
Publicado em 1984

Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancer

Por Leonard, R C F
Publicado em 2001

The Association of Cancer Physicians Breast Cancer Forum: Implications of Calman–Hine for breast cancer services

Por Leonard, R C F
Publicado em 2000

Behçet's syndrome and neutropenia

Por Leonard, R. C. F., Thompson, R. B.
Publicado em 1981

Impact of neutropenia on delivering planned adjuvant chemotherapy: UK audit of primary breast cancer patients

Por Leonard, R C F, Miles, D, Thomas, R, Nussey, F
Publicado em 2003

Paradoxical embolism associated with patent foramen ovale

Por Leonard, R. C. F., Neville, E., Hall, R. J. C.
Publicado em 1981

Metoclopramide versus chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs

Por Allan, S G, Bayliss, E J, Warrington, P S, Leonard, R C F
Publicado em 1985

Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer

Por Cameron, D A, Massie, C, Kerr, G, Leonard, R C F
Publicado em 2003

Limitations of the use of single base changes in the p53 gene to detect minimal residual disease of breast cancer

Por Dang, R K B, Anthony, R S, Craig, J I O, Leonard, R C F, Parker, A C
Publicado em 2002

Breast cancer

Por Allan, S G, Chetty, U, Forrest, A P M, Rodger, A, Smyth, J F, Leonard, R C F
Publicado em 1985

Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4

Por Lodge, A J, Anderson, J J, Gullick, W J, Haugk, B, Leonard, R C F, Angus, B
Publicado em 2003

Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer

Por Malinovszky, K M, Gould, A, Foster, E, Cameron, D, Humphreys, A, Crown, J, Leonard, R C F
Publicado em 2006

Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response

Por Cameron, D A, Gregory, W M, Bowman, A, Anderson, E D C, Levack, P, Forouhi, P, Leonard, R C F
Publicado em 2000

Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?

Por Cameron, D A, Anderson, A, Toy, E, Evans, T R J, Le Vay, J H, Kennedy, I C S, Grieve, R J, Perren, T J, Jones, A, Mansi, J, Crown, J, Leonard, R C F
Publicado em 2002